These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 21426010)

  • 21. Antiviral drugs: Novel antibodies defeat dengue virus.
    Crunkhorn S
    Nat Rev Drug Discov; 2015 Sep; 14(9):601. PubMed ID: 26272188
    [No Abstract]   [Full Text] [Related]  

  • 22. A Novel Iminosugar UV-12 with Activity against the Diverse Viruses Influenza and Dengue (Novel Iminosugar Antiviral for Influenza and Dengue).
    Warfield KL; Plummer E; Alonzi DS; Wolfe GW; Sampath A; Nguyen T; Butters TD; Enterlein SG; Stavale EJ; Shresta S; Ramstedt U
    Viruses; 2015 May; 7(5):2404-27. PubMed ID: 25984714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel concept on antiviral strategies to dengue.
    Lo YC; Perng GC
    Curr Opin Virol; 2016 Jun; 18():97-108. PubMed ID: 27284691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Towards the design of antiviral inhibitors against flaviviruses: the case for the multifunctional NS3 protein from Dengue virus as a target.
    Lescar J; Luo D; Xu T; Sampath A; Lim SP; Canard B; Vasudevan SG
    Antiviral Res; 2008 Nov; 80(2):94-101. PubMed ID: 18674567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Highly potent and selective inhibition of bovine viral diarrhea virus replication by γ-carboline derivatives.
    Salim MT; Goto Y; Hamasaki T; Okamoto M; Aoyama H; Hashimoto Y; Musiu S; Paeshuyse J; Neyts J; Froeyen M; Herdewijn P; Baba M
    Antiviral Res; 2010 Dec; 88(3):263-8. PubMed ID: 20869990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interference in dengue virus adsorption and uncoating by carrageenans.
    Talarico LB; Damonte EB
    Virology; 2007 Jul; 363(2):473-85. PubMed ID: 17337028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro inhibition of dengue virus entry by p-sulfoxy-cinnamic acid and structurally related combinatorial chemistries.
    Rees CR; Costin JM; Fink RC; McMichael M; Fontaine KA; Isern S; Michael SF
    Antiviral Res; 2008 Nov; 80(2):135-42. PubMed ID: 18606464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of dengue virus replication by mycophenolic acid and ribavirin.
    Takhampunya R; Ubol S; Houng HS; Cameron CE; Padmanabhan R
    J Gen Virol; 2006 Jul; 87(Pt 7):1947-1952. PubMed ID: 16760396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic effects of dengue 2 virus capsid protein and staphylococcal nuclease fusion protein on dengue-infected cell cultures.
    Qin CF; Qin E; Yu M; Chen SP; Jiang T; Deng YQ; Duan HY; Zhao H
    Arch Virol; 2005 Apr; 150(4):659-69. PubMed ID: 15592886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Celgosivir treatment misfolds dengue virus NS1 protein, induces cellular pro-survival genes and protects against lethal challenge mouse model.
    Rathore AP; Paradkar PN; Watanabe S; Tan KH; Sung C; Connolly JE; Low J; Ooi EE; Vasudevan SG
    Antiviral Res; 2011 Dec; 92(3):453-60. PubMed ID: 22020302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quercetin derivatives as non-nucleoside inhibitors for dengue polymerase: molecular docking, molecular dynamics simulation, and binding free energy calculation.
    Anusuya S; Gromiha MM
    J Biomol Struct Dyn; 2017 Oct; 35(13):2895-2909. PubMed ID: 27608509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interferon inhibits dengue virus infection by preventing translation of viral RNA through a PKR-independent mechanism.
    Diamond MS; Harris E
    Virology; 2001 Oct; 289(2):297-311. PubMed ID: 11689052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of dengue antiviral candidates in vivo in mouse model.
    Watanabe S; Vasudevan SG
    Methods Mol Biol; 2014; 1138():391-400. PubMed ID: 24696350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Repurposing of prochlorperazine for use against dengue virus infection.
    Simanjuntak Y; Liang JJ; Lee YL; Lin YL
    J Infect Dis; 2015 Feb; 211(3):394-404. PubMed ID: 25028694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nucleobases and corresponding nucleosides display potent antiviral activities against dengue virus possibly through viral lethal mutagenesis.
    Qiu L; Patterson SE; Bonnac LF; Geraghty RJ
    PLoS Negl Trop Dis; 2018 Apr; 12(4):e0006421. PubMed ID: 29672522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure-activity relationship study of biflavonoids on the Dengue virus polymerase DENV-NS5 RdRp.
    Coulerie P; Nour M; Maciuk A; Eydoux C; Guillemot JC; Lebouvier N; Hnawia E; Leblanc K; Lewin G; Canard B; Figadère B
    Planta Med; 2013 Sep; 79(14):1313-8. PubMed ID: 23929244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quinic acid derivatives inhibit dengue virus replication in vitro.
    Zanello PR; Koishi AC; Rezende Júnior Cde O; Oliveira LA; Pereira AA; de Almeida MV; Duarte dos Santos CN; Bordignon J
    Virol J; 2015 Dec; 12():223. PubMed ID: 26695767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activity of andrographolide against dengue virus.
    Panraksa P; Ramphan S; Khongwichit S; Smith DR
    Antiviral Res; 2017 Mar; 139():69-78. PubMed ID: 28034742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitory effect of doxycycline against dengue virus replication in vitro.
    Rothan HA; Mohamed Z; Paydar M; Rahman NA; Yusof R
    Arch Virol; 2014 Apr; 159(4):711-8. PubMed ID: 24142271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A small molecule fusion inhibitor of dengue virus.
    Poh MK; Yip A; Zhang S; Priestle JP; Ma NL; Smit JM; Wilschut J; Shi PY; Wenk MR; Schul W
    Antiviral Res; 2009 Dec; 84(3):260-6. PubMed ID: 19800368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.